Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy
about
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis.Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.Severe refractory CIDP: a case series of 10 patients treated with bortezomib.Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCsCharacterization of a rat model of bortezomib-induced painful neuropathy.The proteasome and proteasome inhibitors in multiple myeloma.Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.The advantages of switch to subcutaneous bortezomib in the real life.
P2860
Q36302859-611F16BB-2BDA-4E9D-98A6-EF77DA80EC14Q37662576-04A92BB3-4ADE-46F3-A26B-D1733101CEB0Q40081746-10CD27F9-6570-4476-A4F5-747291D36265Q42335813-7D61DF82-9732-4FA0-9EA7-971EAF9BDA2BQ42361271-F80CB464-BAC0-4E95-950E-88376CAE5E67Q47120603-D2A599F1-C612-4905-9638-08C6397FC2E4Q47339695-451D22AF-BE2E-4E20-A9EE-86A76BD91576Q47899730-38919AE8-11DA-49D1-AB5B-C436E42FA1FBQ49586601-76A64EE2-FB85-41EF-839B-98D127A07A25
P2860
Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Subcutaneous bortezomib in mul ...... dence of peripheral neuropathy
@ast
Subcutaneous bortezomib in mul ...... dence of peripheral neuropathy
@en
type
label
Subcutaneous bortezomib in mul ...... dence of peripheral neuropathy
@ast
Subcutaneous bortezomib in mul ...... dence of peripheral neuropathy
@en
prefLabel
Subcutaneous bortezomib in mul ...... dence of peripheral neuropathy
@ast
Subcutaneous bortezomib in mul ...... dence of peripheral neuropathy
@en
P2093
P2860
P50
P1433
P1476
Subcutaneous bortezomib in mul ...... dence of peripheral neuropathy
@en
P2093
Czech Myeloma Group
Dagmar Adamova
Evzen Gregora
Jan Straub
Jarmila Obernauerova
Jaromir Gumulec
Jaroslav Bacovsky
Jiri Jarkovsky
Jiri Minarik
Lenka Walterova
P2860
P304
P356
10.1371/JOURNAL.PONE.0123866
P407
P577
2015-04-14T00:00:00Z